Despite both being classified as MiT family tRCC, TFE3 fusion tumors were relatively more aggressive, while TFEB fusion tumors had a better prognosis1,57. This evidence concerns the gene TFE3 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.